Sandra J. Lee
Impact in
Papers in
- Oncology 64
- Cutaneous Melanoma Detection and Management 22
- Global Cancer Incidence and Screening 22
- Cancer Immunotherapy and Biomarkers 16
- CAR-T cell therapy research 15
-
- Melanoma and MAPK Pathways 17
- Co-authors
- John M. Kirkwood (33 shared papers)Marvin Zelen (8 shared papers)Judy Lieberman (4 shared papers)Deborah Palliser (2 shared papers)Vernon K. Sondak (12 shared papers)Roderick T. Bronson (1 shared paper)David M. Knipe (1 shared paper)Dipanjan Chowdhury (1 shared paper)
- Journals
- Journal of Clinical Oncology (23 papers)Clinical Cancer Research (8 papers)JNCI Journal of the National Cancer Institute (5 papers)Medical Decision Making (5 papers)Cancer (3 papers)
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
Sandra J. Lee
93 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Oncology 1.8k
- Virology 229
- Cancer Research 505
- Immunology 650
- Molecular Biology 1.2k
Countries citing papers authored by Sandra J. Lee
This map shows the geographic impact of Sandra J. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra J. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra J. Lee more than expected).
Fields of papers citing papers by Sandra J. Lee
This network shows the impact of papers produced by Sandra J. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra J. Lee. The network helps show where Sandra J. Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandra J. Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials Hit paper breakdown → | 2008 | 534 |
| 2 | 2005 | 317 | |
| 3 | 2004 | 180 | |
| 4 | 2012 | 160 | |
| 5 | 2002 | 145 | |
| 6 | 2014 | 114 | |
| 7 | 2014 | 110 | |
| 8 | 2021 | 100 | |
| 9 | Analysis of Breast Cancer Mortality in the US—1975 to 2019 Hit paper breakdown → | 2024 | 89 |
| 10 | 2018 | 85 | |
| 11 | 2013 | 82 | |
| 12 | 2021 | 76 | |
| 13 | 2009 | 71 | |
| 14 | 2014 | 56 | |
| 15 | 2013 | 53 | |
| 16 | 2008 | 52 | |
| 17 | 2019 | 51 | |
| 18 | 1998 | 50 | |
| 19 | 2010 | 49 | |
| 20 | 2000 | 47 |
About Sandra J. Lee
Sandra J. Lee is a scholar working on Oncology, Molecular Biology, Immunology, Cancer Research and Epidemiology, having authored 98 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (22 papers), Global Cancer Incidence and Screening (22 papers), Melanoma and MAPK Pathways (17 papers), Cancer Immunotherapy and Biomarkers (16 papers), CAR-T cell therapy research (15 papers), Immunotherapy and Immune Responses (14 papers), Breast Cancer Treatment Studies (11 papers) and HIV Research and Treatment (10 papers). The work is most often cited by research in Oncology (1.8k citations), Virology (229 citations), Cancer Research (505 citations), Immunology (650 citations) and Molecular Biology (1.2k citations). Sandra J. Lee has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include John M. Kirkwood, Marvin Zelen, Judy Lieberman, Deborah Palliser, Vernon K. Sondak, Roderick T. Bronson, David M. Knipe, Dipanjan Chowdhury, Qing-Yin Wang and Michael B. Atkins. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, JNCI Journal of the National Cancer Institute, Medical Decision Making and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.